Neoadjuvante Therapie mit 177Lu-DOTATATE bei nichtfunktionellen neuroendokrinen Tumoren des Pankreas (NEOLUPANET): eine multizentrische Phase-II-StudieNeoadjuvant treatment with 177Lu-DOTATATE for nonfunctional neuroendocrine tumors of the pancreas (NEOLUPANET): a multicenter phase II study

被引：0
|
作者：
Ioannis Mintziras [1 ]
Detlef K. Bartsch [1 ]
机构：
[1] Philipps-Universität Marburg,Klinik für Visceral‑, Thorax
来源：
Die Chirurgie | 2025年 / 96卷 / 1期
关键词：
D O I：
10.1007/s00104-024-02205-8
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：63 / 64
页数：1
相关论文
共 28 条
  • [1] Neoadjuvant treatment with 177Lu-DOTATATE for nonfunctional neuroendocrine tumors of the pancreas (NEOLUPANET): a multicenter phase II study
    Mintziras, Ioannis
    Bartsch, Detlef K.
    CHIRURGIE, 2025, 96 (01): : 63 - 64
  • [2] Neoadjuvant 177Lu-DOTATATE for non-functioning pancreatic neuroendocrine tumours (NEOLUPANET): multicentre phase II study
    Partelli, Stefano
    Landoni, Luca
    Bartolomei, Mirco
    Zerbi, Alessandro
    Grana, Chiara Maria
    Boggi, Ugo
    Butturini, Giovanni
    Casadei, Riccardo
    Salvia, Roberto
    Falconi, Massimo
    BRITISH JOURNAL OF SURGERY, 2024, 111 (09)
  • [3] A multicenter phase 2 randomised controlled trial comparing 177Lu-Dotatate and capecitabine combination treatment with 177Lu-Dotatate in neuroendocrine tumor patients
    Becx, M.
    Hofland, J.
    Nonnekens, J.
    Krenning, E.
    Wyld, D.
    Verburg, F.
    Brabander, T.
    de Herder, W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S122 - S123
  • [4] A prospective phase II single-arm trial on neoadjuvant peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE followed by surgery for pancreatic neuroendocrine tumors (NeoLuPaNET)
    Partelli, S.
    Landoni, L.
    Bartolomei, M.
    Zerbi, A.
    Grana, C. M.
    Boggi, U.
    Butturini, G.
    Casadei, R.
    Bassi, C.
    Falconi, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S703 - S703
  • [5] Efficacy of 177Lu-Dotatate Induction and Maintenance Therapy of Various Types of Neuroendocrine Tumors: A Phase II Registry Study
    Sistani, Golmehr
    Sutherland, Duncan E. K.
    Mujoomdar, Amol
    Wiseman, Daniele P.
    Khatami, Alireza
    Tsvetkova, Elena
    Reid, Robert H.
    Laidley, David T.
    CURRENT ONCOLOGY, 2021, 28 (01) : 115 - 127
  • [6] 177Lu-DOTATATE efficacy and safety in functioning neuroendocrine tumors: a joint analysis of phase II prospective clinical trials
    Bongiovanni, A.
    Nicolini, S.
    Foca, F.
    Ibrahim, T.
    Sansovini, M.
    Grassi, I.
    Liverani, C.
    Riva, N.
    Bocchini, M.
    Moretti, A.
    Matteucci, F.
    Fabbri, L.
    Signoretti, M.
    Pacilio, C. A.
    Galassi, R.
    Paganelli, G.
    Severi, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S569 - S569
  • [7] 177Lu-DOTATATE efficacy and safety in functioning neuroendocrine tumors: A joint analysis of phase II prospective clinical trials
    Bongiovanni, A.
    Nicolini, S.
    Foca, F.
    Sansovini, M.
    Grassi, I.
    Liverani, C.
    Riva, N.
    Fausti, V.
    Mercatali, L.
    De Vita, A.
    Fabbri, L.
    Signoretti, M.
    Pacilio, C. A.
    Paganelli, G.
    Severi, S.
    Ibrahim, T.
    Tartaglia, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S912 - S912
  • [8] 177Lu-DOTATATE Efficacy and Safety in Functioning Neuroendocrine Tumors: A Joint Analysis of Phase II Prospective Clinical Trials
    Bongiovanni, Alberto
    Nicolini, Silvia
    Ibrahim, Toni
    Foca, Flavia
    Sansovini, Maddalena
    Di Paolo, Arianna
    Grassi, Ilaria
    Liverani, Chiara
    Calabrese, Chiara
    Ranallo, Nicoletta
    Matteucci, Federica
    Paganelli, Giovanni
    Severi, Stefano
    CANCERS, 2022, 14 (24)
  • [9] Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study
    Bodei, Lisa
    Cremonesi, Marta
    Grana, Chiara M.
    Fazio, Nicola
    Iodice, Simona
    Baio, Silvia M.
    Bartolomei, Mirco
    Lombardo, Dario
    Ferrari, Mahila E.
    Sansovini, Maddalena
    Chinol, Marco
    Paganelli, Giovanni
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (12) : 2125 - 2135
  • [10] Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study
    Lisa Bodei
    Marta Cremonesi
    Chiara M. Grana
    Nicola Fazio
    Simona Iodice
    Silvia M. Baio
    Mirco Bartolomei
    Dario Lombardo
    Mahila E. Ferrari
    Maddalena Sansovini
    Marco Chinol
    Giovanni Paganelli
    European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 : 2125 - 2135
123